Pasithea Therapeutics Corp [NASDAQ: KTTA] jumped around 0.1 points on Wednesday, while shares priced at $0.96 at the close of the session, up 11.07%.
Compared to the average trading volume of 5.68M shares, KTTA reached a trading volume of 14595592 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Pasithea Therapeutics Corp [KTTA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KTTA shares is $40.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KTTA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Pasithea Therapeutics Corp is set at 0.30 The Price to Book ratio for the last quarter was 0.09, with the Price to Cash per share for the same quarter was set at 1.14.
How has KTTA stock performed recently?
Pasithea Therapeutics Corp [KTTA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.47. With this latest performance, KTTA shares dropped by -19.05% in over the last four-week period, additionally sinking by -71.14% over the last 6 months – not to mention a drop of -86.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KTTA stock in for the last two-week period is set at 37.73, with the RSI for the last a single of trading hit 34.47, and the three-weeks RSI is set at 39.91 for Pasithea Therapeutics Corp [KTTA]. The present Moving Average for the last 50 days of trading for this stock 1.2777, while it was recorded at 0.8952 for the last single week of trading, and 2.9292 for the last 200 days.
Pasithea Therapeutics Corp [KTTA]: Deeper insight into the fundamentals
Pasithea Therapeutics Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.58 and a Current Ratio set at 6.58.
Insider trade positions for Pasithea Therapeutics Corp [KTTA]
There are presently around $15.05%, or 15.68%% of KTTA stock, in the hands of institutional investors.
